APA (7th ed.) Citation

Neri, A., Marmiroli, S., Tassone, P., Lombardi, L., Nobili, L., Verdelli, D., . . . Sacchi, S. (2008). The oral protein-kinase C β inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines. Leukemia & Lymphoma, 49(7), 1374. https://doi.org/10.1080/10428190802078289

Chicago Style (17th ed.) Citation

Neri, Antonino, et al. "The Oral Protein-kinase C β Inhibitor Enzastaurin (LY317615) Suppresses Signalling Through the AKT Pathway, Inhibits Proliferation and Induces Apoptosis in Multiple Myeloma Cell Lines." Leukemia & Lymphoma 49, no. 7 (2008): 1374. https://doi.org/10.1080/10428190802078289.

MLA (9th ed.) Citation

Neri, Antonino, et al. "The Oral Protein-kinase C β Inhibitor Enzastaurin (LY317615) Suppresses Signalling Through the AKT Pathway, Inhibits Proliferation and Induces Apoptosis in Multiple Myeloma Cell Lines." Leukemia & Lymphoma, vol. 49, no. 7, 2008, p. 1374, https://doi.org/10.1080/10428190802078289.